Episodes

  • The $2tn man
    Oct 17 2024

    Nicolai Tangen oversees Norges Bank Investment Management, also known as Norway’s oil fund. It contains about $2tn in assets, based on money earned from drilling for oil offseas. Today on the show, Tangen talks with Katie Martin about everything from the European economy to China and Taiwan to overconcentration in the American stock markets. Also, Tangen goes long learning and short red tape.


    For a free 30-day trial to the Unhedged newsletter go to: https://www.ft.com/unhedgedoffer


    You can email Robert Armstrong at robert.armstrong@ft.com and Katie Martin at katie.martin@ft.com.


    Unhedged has been nominated for a Signal Award! You can vote for us here: https://vote.signalaward.com/PublicVoting#/2024/shows/general/money-finance


    Read a transcript of this episode on FT.com


    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    21 mins
  • Are emerging markets back?
    Oct 15 2024

    Grouping the majority of the world’s economies into a basket labelled “emerging markets” and trying to generalise about them is a fool’s errand. And we are perfect for the job. Today on the show, Katie Martin and Aiden Reiter discuss the EM landscape and pay particular attention to Brazil’s hot economy. Also we go long Poppy Gustafsson and short Netflix’s research department.


    For a free 30-day trial to the Unhedged newsletter go to: https://www.ft.com/unhedgedoffer


    You can email Robert Armstrong at robert.armstrong@ft.com and Katie Martin at katie.martin@ft.com.


    Unhedged has been nominated for a Signal Award! You can vote for us here: https://vote.signalaward.com/PublicVoting#/2024/shows/general/money-finance


    Read a transcript of this episode on FT.com


    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    20 mins
  • Novo Nordisk, Eli Lilly and the GLP-1 economy
    Oct 10 2024

    Eli Lilly’s shares have surged 750 per cent over five years. Novo Nordisk’s are up about 360 per cent in the same period. It's been an awesome run for these companies. But how much longer can it last? Today on the show, Rob Armstrong and Aiden Reiter talk to the FT’s US pharmaceutical and biotech correspondent Oliver Barnes about the astonishing growth in weight-loss drugs, and their future. Also we short inflation and running clubs.


    For a free 30-day trial to the Unhedged newsletter go to: https://www.ft.com/unhedgedoffer


    You can email Robert Armstrong at robert.armstrong@ft.com and Katie Martin at katie.martin@ft.com.


    Unhedged has been nominated for a Signal Award! You can vote for us here: https://vote.signalaward.com/PublicVoting#/2024/shows/general/money-finance


    Read a transcript of this episode on FT.com


    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    21 mins
  • Markets send mixed signals
    Oct 8 2024

    Stocks are flying, rates are plunging, jobs are surging, but everyone says they’re anxious. What is going on? Today on the show, Katie Martin and Rob Armstrong try to understand the many strange and sometimes contradictory things happening in the US economy. Also, we go short Spirit Halloween and long monsters.


    For a free 30-day trial to the Unhedged newsletter go to: https://www.ft.com/unhedgedoffer


    You can email Robert Armstrong at robert.armstrong@ft.com and Katie Martin at katie.martin@ft.com.


    Unhedged has been nominated for a Signal Award! You can vote for us here: https://vote.signalaward.com/PublicVoting#/2024/shows/general/money-finance


    Read a transcript of this episode on FT.com


    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    21 mins
  • Markets and the Middle East
    Oct 3 2024

    As the conflict in the Middle East expands to include Lebanon and Iran, markets are responding with surprising nonchalance. Why? And will that last? Today on the show, Katie Martin and capital markets correspondent Nick Megaw try to understand why so much can go wrong in one part of the world, without roiling markets in the rest of the world. Also, we go long the Vix, and short e-cycles.


    For a free 30-day trial to the Unhedged newsletter go to: https://www.ft.com/unhedgedoffer


    You can email Robert Armstrong at robert.armstrong@ft.com and Katie Martin at katie.martin@ft.com.


    Unhedged has been nominated for a Signal Award! You can vote for us here: https://vote.signalaward.com/PublicVoting#/2024/shows/general/money-finance


    Read a transcript of this episode on FT.com


    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    16 mins
  • Is the China stimulus package enough?
    Oct 1 2024

    Last week China announced it would be providing low-cost funds to investors in both equities and the property market. The nominal effects were immediate, and the country’s stock market has recently risen as much as 20 per cent. Boosting stock prices is one thing, but there is a bigger problem: can Beijing encourage more domestic spending, and less saving? Today on the show, Katie Martin discusses all this with the Unhedged newsletter's newest writer, Aiden Reiter, who, it turns out, speaks Mandarin. Also we go long morning swims and long our own show.


    For a free 30-day trial to the Unhedged newsletter go to: https://www.ft.com/unhedgedoffer


    You can email Katie Martin at katie.martin@ft.com and Aiden Reiter at aiden.reiter@ft.com.


    Read a transcript of this episode on FT.com



    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    17 mins
  • Immigration and unemployment
    Sep 26 2024

    When discussing the economy after the interest rate cuts last week, chair of the US Federal Reserve Jay Powell made an interesting comment about jobs numbers and immigration. “If you are having millions of people come into the labour force, and you are creating 100,000 jobs, you’re going to see unemployment go up,” he said. Well, mostly. Today on the show, the entire staff of the Unhedged newsletter – Rob Armstrong and Aiden Reiter – get together to discuss how immigration might be affecting unemployment. Also, they go long and short China’s new stimulus programmes.


    For a free 30-day trial to the Unhedged newsletter go to: https://www.ft.com/unhedgedoffer


    You can email Robert Armstrong at robert.armstrong@ft.com and Katie Martin at katie.martin@ft.com.


    Read a transcript of this episode on FT.com


    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    19 mins
  • The case for small and mid caps
    Sep 24 2024

    As the Federal Reserve starts to lower interest rates, a perennial theory has returned: that small and mid caps will, for a time, grow more quickly than the S&P 500. Today on the show, Katie Martin, Rob Armstrong, and Aiden Reiter discuss whether that is good, or even true. Also, as the seasons change, we go long and short knitwear.


    For a free 30-day trial to the Unhedged newsletter go to: https://www.ft.com/unhedgedoffer


    You can email Robert Armstrong at robert.armstrong@ft.com and Katie Martin at katie.martin@ft.com.


    Read a transcript of this episode on FT.com


    Hosted on Acast. See acast.com/privacy for more information.

    Show more Show less
    22 mins